+41 91 682 20 40
info@elixi-int.com
Reserved Area
Login
Register
Request Document
Send Document
Home
About Us
Services
Quality
News
Case Studies
Contact
Let's talk
info@yourwebsite.com
+1 (555) 123-4567
Search
non-Hodgkin lymphoma
9 February 2021
Breyanzi (lisocabtagene maraleucel), new Treatment For Adults With Relapsed Or Refractory Large-B-Cell Lymphoma
by Elixi
19 January 2021
XALKORI (CRIZOTINIB) approved for ALK-POSITIVE anaplastic large cell LYMPHOMA in children and young adults
by Elixi
